Nomura Holdings Inc Fibrogen Inc Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $150,155 - $392,940	-14,750 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $273,907 - $526,280	14,750 New	14,750 $394,000
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $553,690 - $728,110	-17,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $396,100 - $781,320	17,000 New	17,000 $589,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.